Wei Li
36Patents
12h-index
71Co-inventors
84Inventor score
Filing activity: Sep 2, 2003 → Nov 22, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8153162B2 | Purified amniotic membrane compositions and methods of use | Human Necessities | 94 | Active |
| US8182841B2 | Amniotic membrane preparations and purified compositions and anti-inflammation methods | Human Necessities | 65 | Active |
| US8182840B2 | Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition | Human Necessities | 63 | Active |
| US8187639B2 | Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment | Human Necessities | 61 | Active |
| US8460714B2 | Purified amniotic membrane compositions and methods of use | Human Necessities | 39 | Active |
| US8440235B2 | Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition | Human Necessities | 38 | Active |
| US8455009B2 | Amniotic membrane preparations and purified compositions and anti-inflammation methods | Human Necessities | 37 | Active |
| US8420126B2 | Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment | Human Necessities | 36 | Active |
| US9198939B2 | Purified amniotic membrane compositions and methods of use | Human Necessities | 16 | Active |
| US9161955B2 | Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition | Human Necessities | 16 | Active |
| US9161954B2 | Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment | Human Necessities | 14 | Active |
| US9161956B2 | Amniotic membrane preparations and purified compositions and anti-inflammation methods | Human Necessities | 14 | Active |
| US9956252B2 | Purified amniotic membrane compositions and methods of use | Human Necessities | 6 | Active |
| US9750772B2 | Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment | Human Necessities | 6 | Active |
| US9724370B2 | Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition | Human Necessities | 5 | Active |
| US9750771B2 | Amniotic membrane preparations and purified compositions and anti-inflammation methods | Human Necessities | 5 | Active |
| US9346815B2 | 5-chloro-2-difluoromethoxyphenyl pyrazolopyrimidine compounds, compositions and methods of use thereof | Chemistry; Metallurgy | 3 | Active |
| US9266961B2 | Anti-PCSK9 antibodies, formulations, dosing, and methods of use | Chemistry; Metallurgy | 3 | Active |
| US10272119B2 | Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition | Human Necessities | 2 | Active |
| US11155557B2 | Pyrazolopyrimidine compounds and methods of use thereof | Chemistry; Metallurgy | 1 | Active |
| US9873709B2 | Triazolopyridine compounds, compositions and methods of use thereof | Chemistry; Metallurgy | 1 | Active |
| US9604984B2 | 5-chloro-2-difluoromethoxyphenyl pyrazolopyrimidine compounds, compositions and methods of use thereof | Chemistry; Metallurgy | 1 | Active |
| US8303946B2 | Methods and compositions for inhibition of viral replication | Emerging Cross-Sectional Technologies | 1 | Expired |
| US10632155B2 | Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition | Human Necessities | 1 | Active |
| US11731943B2 | Therapeutic compounds, compositions and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.